Edesa Biotech Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
EDSA Nasdaq 8731 https://www.edesabiotech.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Edesa Biotech Inc

Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate - Sep 28th, 2023 12:15 pm
EDSA: EB05 Inhibits Inflammation Initiated by Multiple Pathogens In Vitro… - Aug 16th, 2023 3:40 pm
Edesa Biotech Reports Fiscal Third Quarter 2023 Results - Aug 9th, 2023 8:15 pm
Companies Like Edesa Biotech (NASDAQ:EDSA) Could Be Quite Risky - Aug 4th, 2023 12:56 pm
Edesa Biotech to Participate in Upcoming Canaccord Genuity Growth Conference - Jul 26th, 2023 1:00 pm
Edesa Biotech's COVID-19 Candidate Restraints Inflammation From Influenza, Other Pathogens In Preclinical Studies - Jun 28th, 2023 7:55 pm
Edesa Biotech's ARDS Drug Inhibits Inflammation from Influenza and Other Pathogens - Jun 28th, 2023 11:55 am
Edesa Biotech Appoints Biotech Deal Veteran to CFO Role - Jun 27th, 2023 12:15 pm
Edesa Biotech Anti-Inflammatory Drug Candidate Assigned Name - Jun 15th, 2023 12:00 pm
EDSA: FDA Agrees on Primary Endpoint for Phase 3 ARDS Drug Study… - May 17th, 2023 12:22 pm
Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results - May 11th, 2023 8:30 pm
Edesa Biotech to Participate in Swiss Biotech Day - Apr 20th, 2023 12:30 pm
The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidate - Apr 4th, 2023 12:45 pm
Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Disease Conference - Mar 23rd, 2023 8:30 pm
Edesa Biotech to Present Favorable Dermatitis Drug Results at American Academy of Dermatology Association Annual Meeting - Mar 16th, 2023 8:10 pm
Edesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Study - Mar 15th, 2023 12:10 pm
EDSA: Positive News Flow to Start 2023… - Feb 15th, 2023 10:11 am
Is Edesa Biotech (NASDAQ:EDSA) In A Good Position To Invest In Growth? - Feb 12th, 2023 2:00 pm
Edesa Biotech Reports Fiscal 1st Quarter 2023 Results - Feb 10th, 2023 2:00 pm
Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study - Feb 1st, 2023 1:15 pm